Sign In
Buy NVCR
$16.15
+0.330 (+2.09%)
At Close: Jun 03, 2026
ST. HELIER, Jersey--(BUSINESS WIRE)---- $NVCR #lcsm--The U.S. FDA has approved the IDE application to initiate the KEYNOTE-B36 trial, a collaboration between Novocure and MSD in NSCLC.
Is Novocure a Buy?
06:30am, Tuesday, 20'th Apr 2021
Once a stock goes up 50% in a single day, it can be hard to keep the momentum going.
Why Investors Are So Excited About Novocure
06:04am, Tuesday, 20'th Apr 2021
The company's Tumor Treating Fields therapy looks very promising in treating lung cancer.
Grace Capital's Catherine Faddis on finding market opportunity
08:13am, Monday, 19'th Apr 2021
Catherine Faddis, Founder and CEO of Grace Capital, joins Worldwide Exchange to discuss her market outlook.
NovoCure: The Next Big Healthcare Acquisition
04:21am, Saturday, 17'th Apr 2021
NovoCure continues to build out its product suite. The company is pivoting towards new indications which greatly expands the overall market.
This Stock Just Popped 40%. Here's Why It Can Continue to Crush the Market
06:15am, Friday, 16'th Apr 2021
Novocure has provided stellar returns over the last five years, now up 17 times. Recent positive news may keep its stock going up.
NovoCure, Synchrony, Twitter, Yum! and More Wednesday Afternoon Analyst Calls
11:52am, Wednesday, 14'th Apr 2021
With the trading day about halfway over, the broad markets were again somewhat mixed.
NovoCure (NVCR) Moves 49.6% Higher: Will This Strength Last?
07:39am, Wednesday, 14'th Apr 2021
NovoCure (NVCR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
NVCR Stock: 49.63% Increase Explanation
07:11am, Wednesday, 14'th Apr 2021
The stock price of Novocure Ltd (NASDAQ: NVCR) increased by 49.63% yesterday. This is why it happened.
Novocure exec chairman on studying Tumor Treating Fields
08:12pm, Tuesday, 13'th Apr 2021
Novocure Executive Chairman Bill Doyle discussed studying Tumor Treating Fields, electric fields that disrupt cancer cell division, in stage 4 non-small cell lung cancer.
Why Novocure Stock Skyrocketed Today
05:47pm, Tuesday, 13'th Apr 2021
The oncology specialist's investigational cancer treatment could be a game-changer.
What's Going On With NVCR Stock And VTV Stock Today?
02:07pm, Tuesday, 13'th Apr 2021
Novocure Ltd (NASDAQ: NVCR) shares are trading higher after a data monitoring committee said the interim analysis of the company's Phase 3 LUNAR trial would be accelerated. NovoCure develops commerci
Independent Monitors Suggest Shorter Timeline for Novocure's Lung Cancer Treatment
12:31pm, Tuesday, 13'th Apr 2021
A trial examining the use of Novocure's tumor-treating field technology in non-small cell lung cancer patients could enroll fewer patients over a shorter period, based on recommendations by an indepen
NovoCure surges 65% to all-time high on upbeat review of its lung cancer treatment trial (NVCR)
11:47am, Tuesday, 13'th Apr 2021
NovoCure Limited spiked as much as 65% on Tuesday to its highest since it listed in 2015 after the global oncology company gave an update on its phase three trial for the treatment of non-small cell l
NVCR Stock: The Cancer Therapy News That Has Novocure Shares Skyrocketing Today
10:55am, Tuesday, 13'th Apr 2021
NVCR stock is skyrocketing on Tuesday after cancer treatment firm Novocure received great news regarding its phase 3 tumor treatment trial. The post NVCR Stock: The Cancer Therapy News That Has Novocu
